| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |